June 22, 2022
- Mesenchymal stem cell transplantation in newly diagnosed type-1 diabetes patients: a phase I/II randomized placebo-controlled clinical trial
- A multi-center pediatric to adult care transition intervention program to improve clinic visit adherence and clinical outcomes among adolescents and emerging adults with type 1 diabetes mellitus [PATHWAY]: Protocol for a randomized controlled trial
- Changes in the Co-Expression of Innate Immunity Genes During Persistent Islet Autoimmunity are Associated with Progression of Islet Autoimmunity: The Diabetes Autoimmunity Study in the Young (DAISY)
- Remedy to diabetes distress (R2D2): Development protocol for a scalable screen-to-treat program for families of school-age children
- Umbilical cord blood DNA methylation in children who later develop type 1 diabetes
- Concept of the “Universal Slope”: Toward Substantially Shorter Decentralized Insulin Immunoassays
- Soluble RAGE Prevents Type 1 Diabetes Expanding Functional Regulatory T Cells
- A Novel Intron-Encoded Neuropilin-1 Isoform in Pancreatic Islets Associated With Very Young Age of Onset of Type 1 Diabetes
- Bromocriptine Quick-Release as Adjunct Therapy in Youth and Adults with Type 1 Diabetes: A Randomized, Placebo-Controlled Crossover Study
- The right atrium in young patients with type 1 diabetes mellitus: Insights from the three-dimensional speckle-tracking echocardiographic MAGYAR-Path Study (Full text HTML, PDF)
